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Among the diverse physiological functions exerted by calcium signaling in living cells, its
role in the regulation of protein biogenesis and trafﬁcking remains incompletely under-
stood. In cystic ﬁbrosis (CF) disease the most common CF transmembrane conductance
regulator (CFTR) mutation, F508del-CFTR generates a misprocessed protein that is abnor-
mally retained in the endoplasmic reticulum (ER) compartment, rapidly degraded by the
ubiquitin/proteasome pathway and hence absent at the plasma membrane of CF epithelial
cells. Recent studies have demonstrated that intracellular calcium signals consequent to
activation of apical G-protein-coupled receptors by different agonists are increased in CF
airway epithelia. Moreover, the regulation of various intracellular calcium storage compart-
ments, such as ER is also abnormal in CF cells. Although the molecular mechanism at the
origin of this increase remains puzzling in epithelial cells, the F508del-CFTR mutation is
proposed to be the onset of abnormal Ca2+ inﬂux linking the calcium signaling to CFTR
pathobiology.This article reviews the relationships between CFTR and calcium signaling in
the context of the genetic disease CF.
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INTRODUCTION
Cystic ﬁbrosis (CF) is a genetic disease characterized by abnor-
mal ion transport across the apical plasma membrane (PM) of
many epithelial tissues, including the airways (Riordan, 1993).
Themost commonCFmutationF508del-CF transmembrane con-
ductance regulator (CFTR) is the deletion of phenylalanine at
position 508 (F508del-CFTR) leading to chloride impermeability
in many exocrine glands (salivary, airways, pancreatic) associ-
ated to reduced volume of the ﬁnal secretory ﬂuid (Kerem et al.,
1989; Riordan et al., 1989; Rommens et al., 1989; Quinton, 1990).
CFTR functions as a cyclic AMP-activated and ATP-gated Cl−
channel that is expressed at the apical membrane of a wide vari-
ety of epithelial cell types. Although the gating of the channel is
affected by the F508del-CFTR deletion, the mutant protein retains
some functionality as a Cl− channel (Dalemans et al., 1991).
Moreover, the protein has a much shorter half-life in the PM
than wild-type CFTR (Heda et al., 2001). Therefore, therapeu-
tic efforts have been aimed at overcoming the trafﬁcking defect
in order to increase the amount of functional F508del-CFTR pro-
teins present at the cell membrane (Zeitlin, 2000; Becq, 2010). The
F508del-CFTR proteins have an improper folding leading to its
trapping in the endoplasmic reticulum (ER) by multiple protein
chaperone interactions (Norez et al., 2006b) such as calnexin. Cal-
nexin is a Ca2+-sensitive ER-resident protein that interacts with
monoglucosylated, trimmed intermediates of the N-linked core
glycans on newly synthesized glycoprotein (Helenius and Aebi,
2004). Although CFTR is not a Ca2+-dependent chloride chan-
nel, numerous studies have investigated the role of ER Ca2+ on
CFTR trafﬁcking and in particular in the context of the abnor-
mal F508del-CFTR trafﬁcking. These studies showed for example
that the depletion of ER Ca2+ store by SERCA pump inhibitors
(Thapsigargin, CPA, DBHQ. . .) leads to the partial correction of
abnormal F508del-CFTR trafﬁcking by a mechanism, at least in
part, dependent on decreasing of calnexin–F508del-CFTR inter-
action (Egan et al., 2002, 2004; Norez et al., 2006a). Hence, the
prevention of F508del-CFTR and calnexin interactions became
a valuable target to identify new pharmacological agents able to
restore the abnormal F508del-CFTR trafﬁcking. Some of them are
also able to modify the Ca2+ homeostasis. These results demon-
strated the key role of ER Ca2+ in protein trafﬁcking in epithelial
CF and non-CF cells.
OVERVIEW OF Ca2+ SIGNALING IN NON-EXCITABLE CELLS
The diverse physiological functions of Ca2+ are possible because
of the existence of a large variety of Ca2+ binding proteins that
respond to a rise in [Ca2+]i and transmit the [Ca2+]i information
to speciﬁc effectors. To ensure high ﬁdelity in reading the Ca2+
signal and to minimize the energy invested in the removal of Ca2+
from the cytoplasm at the end of the Ca2+ signal, cells maintain
very low resting [Ca2+]i, usually below 100 nM. The most elemen-
tal mechanism of increasing [Ca2+]i in response to extracellular
stimuli is an inﬂux into the cell of Ca2+ from the extracellular
space, which contains about 2 mM Ca2+.
The ubiquitous mechanism by which external information is
translated into a [Ca2+]i signal is by G-protein-coupled recep-
tors (GPCRs). GPCRS are the largest protein family in mammals,
and decode stimuli that vary from light to pheromones to pep-
tide hormones. With such diversity, GPRCs regulate virtually any
cellular function via multiple second messengers that converge
on all known signaling pathways. GPRCs complexes include the
receptor, a trimeric G-protein composed of Gα and Gβγ subunits
(Gilman, 1987; Freissmuth et al., 1989; Dessauer et al., 1996),
an effector (PLCβ in the case of Ca2+ signaling; Rebecchi and
Pentyala, 2000), and regulators of G-protein signaling (RGS) pro-
teins (Ishii and Kurachi, 2003; Wieland and Mittmann, 2003). In
the case of Ca2+ signaling, the effectors are the different PLCβ
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isoforms, which cleave the minor lipid PIP2, to yield two different
second messengers diacylglycerol (DAG) and IP3. IP3 and DAG
act on separate targets. DAG activates protein kinase C (PKC)
and some transient receptor potential canonical (TRPC) channels,
and IP3 activates the IP3 receptors (IP3Rs) and the Ca2+ release
channels in the ER (Berridge, 1993). Activation of IP3Rs by IP3
releases the Ca2+ stored in the ER to the cytoplasm. Since the ER
spans the entire cell, such a system can deliver Ca2+ to virtually
every domain and every site in the cytoplasm without com-
promising cellular homeostasis or creating large concentration
gradients.
Replenishment of ER Ca2+, by SERCA pump, at the termina-
tion of the stimulation state depends on Ca2+ inﬂux channels at
the PM that sense the Ca2+ content of the ER and open in response
to Ca2+ release from the ER to allow Ca2+ inﬂux into the cyto-
plasm, which is used to reload the ER with Ca2+ (Parekh et al.,
1997; Kiselyov et al., 2003; Parekh and Putney, 2005). Removal of
Ca2+ from the cytoplasmdepends on the activity of the ER and the
PM Ca2+ pumps, SERCA, and PMCA, respectively (Shull, 2000).
The Ca2+ signals that can last for many hours, are in the form of
Ca2+ oscillations with particular amplitude and frequency.
AIRWAY EPITHELIA AND CALCIUM SIGNALING
Changes in cytosolic Ca2+ in non-excitable cells in response to
hormone,growth factor,or cytokine that activateC-type phospho-
lipase (PLC) are biphasic. An initial transient rise is followed by
less pronounced but sustained elevation (Putney, 1987; Berridge
and Irvine, 1989; Berridge, 1993). The initial phase originates from
the inositol trisphosphate-induced release Ca2+ from intracellular
stores and is transient due to the activity of the membrane Ca2+
pumps ATPase. The sustained phase of the increase in cytosolic
Ca2+ requires the continued activation of a Ca2+ inﬂux path-
way to maintain sustained response. In airway epithelial cells like
numerous cell types, the intracellular Ca2+ increase promotes
many cellular processes, as the regulation of Ca2+-activated Cl−
conductance (CaCC) in the airway epithelial (Paradiso et al., 1991;
Grubb et al., 1994). Furthermore, CaCC conductance plays a role
the maintenance of periciliary liquid (PCL) height in CF air-
way epithelia. In CF epithelia the PCL is more rapidly absorbed
from airway surfaces and could not maintain a functional PCL
height/volume under basal conditions. To compensate for the
absence of CFTR–Cl− secretion, the Ca2+ activated Cl− conduc-
tance is thought to play an important role in the regulation of the
height of CF epithelium during the motion phase (Tarran et al.,
2005). These observations highlighted the role of intracellular
Ca2+ and of CaCC conductance in CF physiopathology. More-
over, it has been well established that airway ciliary beat frequency
(CBF) is strongly regulated by second messenger, such as Ca2+
(Lansley et al., 1992; Braiman et al., 1998; Evans and Sanderson,
1999). The CBF is a key factor for the regulation of mucociliary
transport and thus for the mechanisms of defense of the respira-
tory tract (Satir and Sleigh, 1990; Wanner et al., 1996). But still,
Ribeiro et al. (2005a,b) have demonstrated that Ca2+ mobiliza-
tion induced by G-protein-coupled speciﬁc receptors is increased
in human polarized CF epithelial cell compared to control cells
and that these differences appear independent of CFTR mutation,
but are the consequence of cells exposition to infectious factors.
In CF epithelial cells the presence of external Ca2+ ago-
nists (ATP and histamine) induces a higher Ca2+ mobilization
compared to non-CF cells (Antigny et al., 2008a). Several com-
ponents of Ca2+ signaling pathway are disturbed in human
CF cells compared to non-CF cells, and particularly ER Ca2+
release and Ca2+ entry through the PM. At ER level, IP3Rs
Ca2+ release is abnormally increased in CF epithelial cells com-
pared to non-CF cells (Antigny et al., 2009). Abnormal increase
of IP3R Ca2+ release in CF human epithelial cells is proposed
to be the consequence of F508del-CFTR retention in ER com-
partment (Antigny et al., 2009). In airway epithelial cell lines,
the abnormal F508del-CFTR retention provokes concentration of
the ER around nucleus followed by an increase of IP3R activity.
The abnormal F508del-CFTR ER-retention induces an ER con-
densation (Ribeiro et al., 2005a; Antigny et al., 2009), which in
turn, by causing a likely IP3Rs clustering of the ER membrane
could facilitate the formation of highly sensitive Ca2+ release
sites.
Ca2+ SIGNALING IN CFTR PROTEIN CHAPERONING
The ER is a centrally located organelle, which affects most cellu-
lar functions. Its unique luminal environment consists of Ca2+
binding chaperones, which are involved in protein folding, post-
translational modiﬁcation, Ca2+ storage and release, and lipid
synthesis and metabolism (Baumann and Walz, 2001; Berridge,
2002). The lumen of the ER contains many proteins which carry
out these diverse functions (Bergeron et al., 1994; Meldolesi and
Pozzan, 1998; Nicchitta, 1998; Corbett et al., 1999; Corbett and
Michalak, 2000; High et al., 2000; Molinari and Helenius, 2000;
Baumann andWalz, 2001; Jakob et al., 2001). Many severe diseases
result from impaired function of the ER membrane and its pro-
tein folding machinery (Brooks, 1999; Jakob et al., 2001; Sherman
and Goldberg, 2001). Calreticulin, a major Ca2+ binding chap-
erone in the ER, is a key component of the calreticulin/calnexin
cycle which is responsible for the folding of newly synthesized
proteins and glycoproteins and for the quality control pathways
in the ER (Michalak et al., 2002; Gelebart et al., 2005). The func-
tion of calreticulin, calnexin, and other ER proteins is affected
by continuous ﬂuctuations in the concentration of Ca2+ in the
ER. Thus, changes in Ca2+ concentration may play a signaling
role in the lumen of the ER as well as in the cytosol (Micha-
lak et al., 2002). Of note, the decreasing of calnexin–F508del-
CFTR interaction by of ER Ca2+ depletion by SERCA pump
inhibitors leads to the partial correction of abnormal F508del-
CFTR trafﬁcking (Egan et al., 2002, 2004; Norez et al., 2006a).
Recently, Martino et al. (2009) demonstrated that the inﬂamed
CF human bronchial epithelia (HBE), or normal HBE exposed
to supernatant from mucopurulent material (SMM) from CF
airways, exhibit ER/Ca2+ store expansion and ampliﬁed Ca2+-
mediated inﬂammation. HBE inﬂammation triggers an unfolded
protein response (UPR) coupled to mRNA splicing of X-box
binding protein-1 (XBP-1). The link between airway epithelial
inﬂammation, XBP-1s, and ER/Ca2+ store expansion was then
addressed in murine airways challenged with phosphate-buffered
saline or Pseudomonas aeruginosa. P. aeruginosa-challenged mice
exhibited airway epithelial ER/Ca2+ store expansion, which cor-
related with airway inﬂammation. These ﬁndings suggest that, in
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inﬂamed HBE,XBP-1s is responsible for the ER/Ca2+ store expan-
sion that confers ampliﬁcation of Ca2+-dependent inﬂammatory
response.
Ca2+ SIGNALING AND TRPC CHANNELS IN CF CELLS
It is well established that in secretory epithelial cells, the Ca2+
signal is dependent on the polarity of the cells and is always initi-
ated at the apical pole to propagate to the basal pole (Petersen
and Tepikin, 2008). In non-CF cells, there is no evidence in
favor of the involvement of apical CFTR activity in the regu-
lation of Ca2+ homeostasis. On the contrary, in CF cells, the
different Ca2+ responses observed (versus non-CF cells) are
dependent on the presence of CFTR to the PM (Antigny et al.,
2008a). How can this be explained? Among others, one possi-
ble hypothesis is that TRPC channels constitute a missing link
between the abnormal Ca2+ levels observed in CF cells and CFTR
dysfunction.
To test for this hypothesis, the involvement of TRPC channels in
airway epithelial PM Ca2+ inﬂux has been investigated. TRPC are
known to form divalent cation selective and non-selective cation
channels (Nilius and Droogmans, 2001; Clapham, 2003). In res-
piratory diseases, TRPC6 isoform is proposed to contribute to
mucus hypersecretion (Li et al., 2003). Interestingly, it was also
observed that the store operated Ca2+ entry (SOCE), activated by
thapsigargin-ER Ca2+ release in CF cells is similar in non-CF cells,
suggesting that STIM1 protein (Stromal interacting molecule 1;
Liou et al., 2005; Roos et al., 2005; Zhang et al., 2005) and Orai1
(Feske et al., 2005; Vig et al., 2006; Yeromin et al., 2006) channels
are not disrupted in F508del-CFTR expressing cells (Antigny et al.,
2011). Thus,TRPC6 channel could be amajor actor for supporting
the abnormal Ca2+ entry in CF cells. Moreover, recent evidence
also suggests that both wt-CFTR and F508del-CFTR PM proteins
down-regulate the TRPC6-mediated Ca2+ inﬂux and TRPC6 up-
regulates CFTR-dependent Cl− transport (Antigny et al., 2011).
This reciprocal coupling has been observed not only in CF and
non-CF cell lines but also in freshly isolated ciliated human epithe-
lial cells (Antigny et al., 2011). These observations lead to the
emergency of a novel model in which CFTR and TRPC6 are
present within the same complex, each channel regulating the
other.
However, other molecular entities could also support the
abnormal Ca2+ entry in CF cells. For example, a more recent
study suggests that F508del-CFTR cells have enhanced SOCE
which would be mediated by the ER-resident Ca2+ sensor pro-
tein stromal interaction 1 (STIM1) and the Ca2+ release-activated
channel Orai1 (Balghi et al., 2011). It is also proposed that the
Ca2+ up-regulation results from the absence of CFTR at the PM
but would be unrelated to the stimulation of TRPC6 channels
because TRPC6 has not been detected in the cell line CF (Balghi
et al., 2011) whereas it is present in freshly isolated ciliated human
epithelial cells (Antigny et al., 2011).
Thus, further experiments will be needed to clearly understand
the molecular mechanisms leading to PM Ca2+ inﬂux in epithelial
CF and non-CF cells and the role of TRPCs. Several TRPCs can-
didates are now knocking at the door such as TRPC6 and TRPC1
as recently shown in isolated pancreatic acini, a tissue in which
STIM1 regulates TRPC1 (Hong et al., 2010).
Ca2+ SIGNALING IN CF INFLAMMATION
Cystic ﬁbrosis airways are characterized by persistent infections
and an excessive inﬂammatory response (Muhlebach et al., 1999;
Chmiel et al., 2002; Muhlebach and Noah, 2002; Boucher, 2004).
In patients with CF, lack of CFTR–Cl− channel function leads to
progressive pulmonary damage frequently associated with a severe
and persistent neutrophil-dominated endo-bronchial inﬂamma-
tion and bacterial infection (Tirouvanziam, 2006). The molecu-
lar mechanisms connecting abnormal CFTR function in airway
epithelial cells to excessive lung neutrophilic inﬂammation have
not been fully elucidated.
Abnormal CFTR function activity results in airway surface
dehydration and a modiﬁcation of the properties of mucus clear-
ance that participate to the susceptibility of chronic infection
with pathogens such as P. aeruginosa, staphylococcus aureus, and
Haemophilus inﬂuenza (Pier et al., 1996, 1997; Chmiel and Davis,
2003; Donaldson et al., 2006; Boucher, 2007). In response to
bacterial infection,CF airways epithelial cells secrete many inﬂam-
matory mediators into the airway lumen (Levine, 1995; Polito and
Proud, 1998; Diamond et al., 2000). An exaggerated inﬂammatory
response has been demonstrated in vivo and in in vitro studies.
Interleukin-8 (IL-8) levels were increased in bronchial submucosal
glands from patients homozygous for F508del-CFTR mutation
compared to control subjects, and IL-8 release is 13-fold higher in
cultured CF than in normal human bronchial glands (Tabary et al.,
2000). Tabary et al. (2000) have also demonstrated that IL-8 secre-
tion is higher in primary humanbronchial gland cells derived from
F508del-CFTRpatients compared tonon-CFbronchial gland cells.
Then, it has been shown that the intracellular Ca2+ increase is an
intermediary step in the signal transduction events linking cell
stimulation by inﬂammatory factors to NF-κB (Nuclear Factor
Kappa B) activation (Ribeiro et al., 2005a; Tabary et al., 2006).
Moreover, the correction of F508del-CFTR abnormal localization
by an incubation of CF cells at 26˚C promoted a decrease of NF-κB
activity via decrease of Ca2+ release (Tabary et al., 2001).
Ca2+ AND INFECTION IN CF
Two major explanations of the mechanisms of dysregulation of
intracellular Ca2+ homeostasis in CF are the “infection-driven”
and the “mutated CFTR-dependent” mechanistic hypothesis.
Lung mucus production is an adaptive mechanism whose func-
tion is to provide a barrier between lung cells and noxious stimuli
in the inspired air. These include viruses, bacteria, dust particles,
and air pollution. Relevant stimuli for mucus production in CF
include bacterial pathogens and inﬂammation (Oliver et al., 2000).
Persistent mucus hypersecretion is often associated with CF. One
of the stimulatory mechanisms triggered by bacterial pathogens
that contribute to mucin overproduction in CF involves Ca2+
signaling (McNamara and Basbaum, 2001). Indeed, the protein
ﬂagellin is a major structural component of bacterial ﬂagella in
both Gram positive and Gram negative bacteria and it has been
shown that P. aeruginosa ﬂagellin can elicit host cell responses
through binding to a glycolipid receptor, asialoGM1 (ASGM1;
Feldman et al., 1998). McNamara et al. demonstrated that ASGM1
ligation stimulates transcription of the mucin MUC 2 and this
process involves the release of ATP extracellular followed by acti-
vation of cell surface ATP receptors and then Ca2+ mobilization
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(McNamara and Basbaum, 2001). Flagellin increases the associ-
ation between ﬂagellin receptors ASGM1 and Toll-like receptor
2 as well as 5 (TLR2 and TLR5) to stimulate the release of ATP.
ATP binds and activates a G-protein-coupled nucleotide receptor
on the cell surface, leading to Ca2+ mobilization (Adamo et al.,
2004; McNamara et al., 2006). Finally, it is predicted that the
synergistic effects of ATP and other [Ca2+]i-raising agonists to
augment activation by ﬂagellin will be larger in CF cells than in
non-CF cells, potentially contributing to hyperinﬂammation in
CF airways (Fu et al., 2007). More recently, functional studies per-
formed in HBE cells exposed to P. aeruginosa demonstrate that
phospholipase C-β3 (PLCB3), by regulating intracellular calcium
transients, play a relevant role in amplifying the expression and
release of IL-8, the major chemokine recruiting neutrophils in
CF airway lungs (Bezzerri et al., 2011). Balghi et al. (2011) have
demonstrated that elevated Ca2+ signaling in CF cells, is caused
by an increase in the exocytotic insertion of Orai1 into the PM
and the formation of more STIM1/Orai1 complexes during store
depletion. This phenomenon induces the increased SOCE in CF
cells and enhances IL-8 secretion; therefore it may contribute to
the hyperinﬂammatory state that characterizes CF (Balghi et al.,
2011).
Pseudomonas aeruginosa relies on quorum sensing molecules
such as the autoinducer N -3-oxododecanoyl homoserine lactone
(3O-C12) to drive the expression of numerous genes related to
virulence (Erickson et al., 2002), bioﬁlm formation (Singh et al.,
2000), and antibiotic resistance (Möker et al., 2010) when coloniz-
ing the CF lung. The lactone 3O-C12 has been shown to trigger
Ca2+ release from the ER in airway epithelial cells (Schwarzer et al.,
2001). The autoinducer 3O-C12 has been demonstrated to induce
proinﬂammatory cytokine production in airway epithelial cells in
a calcium-dependent manner, and that dysregulated calcium stor-
age or signaling in CF cells results in an increased production of
proinﬂammatory cytokines (Mayer et al., 2011).
In addition, the expansion of ER observed in CF cells (Ribeiro
et al., 2005b;Antigny et al., 2008b) is reversible, in that the removal
of the SMM from infected/inﬂamed bronchi of CF patients nor-
malized the size of the intracellular stores of CF cells and, consis-
tently, non-CF cells show progressive expansion of intracellular
calcium stores after long term incubation in vitro with SMM
(Ribeiro et al., 2005a). Regarding host defense mechanisms that
clear airway surfaces, the raised intracellular Ca2+ release due
to ER expansion may provide an adaptive response for both the
normal andCFairways.AhigherCa2+ mobilizationmaybepartic-
ularly useful toCFpatients,whodepend solely onCa2+-dependent
Cl− channel to compensate for the absent cAMP-mediated Cl−
secretion in CF. However, these data suggested that the increased
ER size and Ca2+ storage, following chronic exposure to bacte-
rial factors, is independent of the intrinsic F508del-CFTR defect
(Ribeiro et al., 2005a). On contrary, the effect of Cftr genotype
on the apoptotic response of airway epithelial cells to P. aerugi-
nosa, indicated that HBE cells expressing F508del-CFTR under-
went signiﬁcantly delayed apoptosis compared to cells expressing
wt-CFTR (Cannon et al., 2003). Moreover, mice with wild-type
Cftr alleles had apoptotic cell in their lungs after P. aeruginosa
infections, whereas mice homozygous for the F508del- or G551D-
Cftr alleles showed little apoptosis in response to acute infection
(Cannon et al., 2003). Then,CFTR-associated defects in apoptosis
may contribute to the pathogenesis of the lung disease in CF.
In conclusion, both major hypothesis are not mutually exclu-
sive, at least since the “mutated CFTR-dependent” mechanism
could be worsened in the progression of the disease by the
“infection-driven” expansion of the intracellular calcium stores.
CALCIUM HOMEOSTASIS AND F508del-CFTR RESCUE
At all hot spots of Ca2+ signaling such as global Ca2+
response, IP3R-dependent Ca2+ release, and TRPC6-dependent-
Ca2+ inﬂux, a normalization of theseCa2+ responseswas observed
by the rescue of F508del-CFTR, after pharmacological treatment
or after 24 h at low temperature (27˚C; Antigny et al., 2008a,
2009, 2011). For example, the daily treatment of CF cells for
2 months with low concentration of the corrector miglustat (N -
butyldeoxynojirimycin), an inhibitor of the α-1,2 glucosidase,
results in progressive, stable reversible, and sustained correction
of F508del-CFTR trafﬁcking (Norez et al., 2009). This progres-
sive correction is also accompanied by a down regulation of Ca2+
homeostasis (Norez et al., 2009). These works demonstrated a
good correlation between the presence of F508del-CFTR at the
PM and the normalization of global Ca2+ mobilization induced
by histamine stimulation.
At the ER level, the IP3R hyper-activity and the ER condensa-
tion observed in CF airway were also normalized by the correction
of abnormal F508del-CFTR trafﬁcking. Moreover, using CF cells
which co-expressed endogenous F508del-CFTR (trapped in the
ER) and exogenous wt-CFTR (localized to the PM), the abnor-
mal IP3R activity observed in CF human epithelial cells appears
to be the consequence of the retention of endogenous F508del-
CFTR in ER compartment (Antigny et al., 2009). In addition to
requiring IP3, IP3R are regulated in a biphasic manner by direct
interaction with Ca2+, i.e., activation at low concentrations (up
to 0.3μM) and inhibition at higher concentrations (0.5–1μM;
Bezprozvanny et al., 1991). These different regulations of IP3Rs by
local Ca2+ concentrations are involved in the complex feedback
regulation of the Ca2+ release (De Smedt et al., 1997). According
to the results of Ribeiro et al. (2005a,b), even in absence of bacte-
rial infection, the ER network is concentrated around the nucleus
and expanded throughout the nucleus in corrected and non-CF
epithelial cells. This expansion or condensation of ER network is
responsible for the variation in local IP3Rs Ca2+ dependent activ-
ity (Antigny et al., 2009). In corrected CF cells, IP3Rs are more
distant from each other, leading to reduce propagation of the Ca2+
wave (Figure 1).
At the PM level, TRPC6 exacerbated activity in CF epithelial
cells could be the result of PM CFTR absence caused by CFTR
mutations and not dependent of CFTR activity (Antigny et al.,
2011). The down regulation of TRPC6 activity by PM CFTR is
reminiscent of the interaction observed for the epithelial Na+
channel (ENaC) and CFTR in airway epithelia (Guggino and Stan-
ton, 2006). Indeed, although still controversial (Itani et al., 2011)
CF disease is also characterized by an Na+ hyperabsorption via the
apical activity of ENaC channels (Donaldson and Boucher, 2007).
CFTR plays a critical role (not fully understood) in the regulation
of ENaC activity via intermolecular interaction (Stutts et al., 1995;
Donaldson and Boucher, 2007). Moreover, as for Ca2+ signaling
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FIGURE 1 | Correlation between ER morphology, IP3R clustering, and
IP3R Ca2+ release plasma. (A) In Non-CF cells, the ER was expended at the
totality of cell surface, IP3Rs are distant between others and the IP3R ER
Ca2+ release was normal (B) In CF cells, the F508del-CFTR was trapped into
ER. The ER was concentrated around the nucleus. IP3Rs are more clustered
and the Ca2+ propagation wave was abnormally increased. ER staining was
performed with ER-tracker (1μM during 15min). The IP3R Ca2+ release was
measured by using NP-EGTA or IP3-caged techniques.
FIGURE 2 | Proposed model linking the F508del-CFTR mutation and Ca2+
homeostasis in airway epithelial cell line. (Left panel) In CF airway
epithelial phenotype, in absence of bacterial infection, the F508del-CFTR
mutation caused the trapped of mutated CFTR protein into the ER, followed
by the ER network condensation, inducing the IP3R clustering. The ﬁnal
consequence was the increased of IP3R activity. Moreover, the CFTR
absence of the plasma membrane (PM) induced a hyper-activity of TRPC6
Ca2+ channel. (Right panel) The abnormal F508del-CFTR trafﬁcking correction
(pharmacologically or low temperature incubation) induced an ER network
expansion. IP3Rs are more distant from each others, leading to reduce Ca2+
release. At PM level, the F508del-CFTR interacted with TRPC6. This
interaction seems to induce a normalization of TRPC6 activity.
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(TRPC6 activity for example) the ENaC activity is also normalized
by the correction of abnormal trafﬁcking of F508del-CFTR (Noel
et al., 2008). Therefore, CFTR seems to control the activity of both
ENaC and TRPC6 channels.
The Ca2+ permeable TRPC cation channels are of particular
interest in the pathophysiology of CF for several reasons. First,
TRPC6 may contribute to mucus hypersecretion, a feature found
in many respiratory diseases, including CF (Li et al., 2003). Sec-
ond, the misregulation of TRPC6 channels may be relevant to CF
disease because it might contribute to the increased Na+ absorp-
tion described in CF airway epithelial, as described with TRPV4
channel (Arniges et al., 2004).
CONCLUSION
The relationship between CFTR and Ca2+ signaling in human
epithelial cells is far from being fully understood. Some studies
showed that the Ca2+ signaling exacerbation in human primary
epithelial cells is independent of CFTR and would be the conse-
quence of the presence of infectious factors. But other studies pro-
posed that perturbation of Ca2+ signaling in CF airway epithelia
cells is a direct consequence of CFTR mutation and misprocessing.
Also, more recent data now suggested a good correlation between
CFTR-related defects and abnormal Ca2+ signaling in CF airway
epithelial cell.
A novel working hypothesis is now emerging, in which CFTR
and TRPC6 channels are both present within a multiprotein
membranous complex, each channel down regulating the other;
i.e., CFTR down-regulates TRPC6-dependent-Ca2+ inﬂux and
TRPC6 up-regulates CFTR-dependent Cl− transport. In addition
STIM1, Orai1, and other TRPCs could also contribute to this sig-
naling pathway. In addition STIM1,Orai1, and other TRPCs could
also contribute to this signaling pathway. A scheme linking the
putative sequence of Ca2+ signal perturbations to F508del-CFTR
mutation is proposed in Figure 2.
Despite the progresses made in recent years to understand the
role of Ca2+ signaling in CF, further experiments will be needed to
dissect and understand the complexity of the regulation of CFTR
protein activity and biogenesis by Ca2+ and to precise the molecu-
lar interactions between CFTR and TRPC proteins as well as their
consequences for the physiopathology of CF.
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